Stuart Schweitzer, Ph.D.

Vice-Chair and Professor of Health Services UCLA School of Public Health Box 951772 Los Angeles, CA 90095-1772 (310) 825-2595 Fax: (310) 825-3317 E-mail: Sschweit@ucla.edu Biosketch

Biographical Information

Stuart O. Schweitzer is Professor of Health Services. He teaches courses in health economics, health system organization and financing, pharmaceuticals, and comparative health systems. Professor Schweitzer earned his Ph.D. in economics from the University of California, Berkeley. He has taught at Wayne State University and Georgetown University, as well as having been on the research staff of The Urban Institute and the National Institutes of Health. He served on President Carter's Commission for a National Agenda for the Eighties, and has held visiting appointments at Oxford University, CREDES (Paris), ESSEC (Paris), the University of Ferrara (Italy), and the Shanghai Medical University. His research interests are in the areas of health policy, especially as they pertain to pharmaceuticals, genetics, and the financing of health care. Dr. Schweitzer directed a 6-year assessment of health screening and promotion for the elderly, financed by the Health Care Financing Administration. He is currently directing a study of drug pricing for developing countries. He co-directs the UCLA Research Program in Pharmaceutical Economics and Policy, with Professors William Comanor and Michael Intriligator.

Selected Publications

Di Tommaso M and Schweitzer SO, eds., Health Policy and High-Tech Industrial Development: Learning from Innovation in the Health Industry, Cheltenham (UK):  Edward Elgar Publishers, 2005.

Schweitzer SO, Pharmaceutical Economics and Policy, New York:  Oxford University Press, 1997.  Second edition (2007).

Schweitzer SO and DiTommaso MR, Industrial Policy Comes to America:  State Intervention and the Future of the American Economy, (Cheltenham UK:  Edward Elgar Publishers), forthcoming.

Journal Articles

Schweitzer SO, “Introduction:  How will health systems adopt new genetics technology?”  in Schweitzer SO, ed., Special Issue on Genetics and Society, International Journal of Healthcare Technology and Management 8(5): 417-425, 2007.

Comanor WS and Schweitzer SO, “Determinants of drug prices and expenditures,” Managerialand Decision Economics 28:1-14, 2007.

Schweitzer SO and Comanor WS, “Controlling Pharmaceutical Prices and Expenditures:     A Review,” in Andersen RA, Rice TH, and Kominski GF, (eds), Changing the U.S. Health Care System (3rd ed), San Francisco, CA: Jossey-Bass, 2007.

Chen Y, Schweitzer SO, “Issues in Drug Pricing, Reimbursement, and Access in China with Reference to the Asia-Pacific Region,” Value in Health 11(Supplement 1:S124-129), 2008.

Schweitzer SO, “Trying Times at the FDA – The Challenge of Ensuring the Safety of Imported Pharmaceuticals,” New England J of Medicine 358(17):1773-1777, April 24, 2008.

Barbieri E,  Schweitzer SO, and Galassi FL, “La localizzazione delle imprese biotech in Italia:analysi e implicazioni per le politiche industriali regionali” (“Regionalization of Biotech Industrial Development in Italy:  Analysis and implications for Industrial Districts,” L’Industria 34(4):7-33, 2009.

Katz G and Schweitzer SO, “Implications of Genetic Testing for Health Policy,” Yale Journal of Health Policy, Law, and Ethics, 10(1):90-134, 2010.

DiTommaso MR and Schweitzer SO (eds), International Journal of Healthcare Technology and Management (Special Issue on University-Industry Technology Transfer in the High-Technology Sector), forthcoming.